Xencor reported $52.25M in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 766M 2787M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
Alnylam Pharmaceuticals ALNY:US $ -189.56M 10.73M
Amgen AMGN:US $ 464M 1182M
Arrowhead Research ARWR:US $ -29924000 3.11M
AstraZeneca AZN:LN 550M 1011M
Biogen BIIB:US $ 448.5M 38.3M
Bristol Myers Squibb BMY:US $ 1055M 966M
Cytokinetics CYTK:US $ -61.55M 14.45M
Epizyme EPZM:US $ -64.36M 5.91M
GlaxoSmithKline GSK:LN 1395M 322M
Johnson & Johnson JNJ:US $ 3667M 2611M
Karyopharm Therapeutics KPTI:US $ -53582000 3.83M
Macrogenics MGNX:US $ -39.94M 11.34M
Merk MRK:US $ 1545M 1634M
Novartis NOVN:VX SF 2896M 837M
Pfizer PFE:US $ 5564M 686M
Regeneron Pharmaceuticals REGN:US $ 3098.9M 1983.7M
Seattle Genetics SGEN:US $ -84.58M 36.84M
Xencor XNCR:US $ 52.25M 54.74M